Why it matters:
a weak validation story turns planned control into regulatory risk.
Validation proves your eQMS is built on a controlled foundation, not just a checkbox project.
Validation expectations span GMP frameworks:
Regulatory callout: regulators expect traceability from requirements to risk, execution, and verification.
Inspectors evaluate whether validation reflects real use:
Inspector insight: outdated validation packages signal lost control.
Validation fails when treated as paperwork:
Failure callout: inspectors dig for evidence that the organization owns its validation story—not just the vendor.
A modern eQMS keeps validation defensible:
Complere keeps validation evidence living inside the quality system so updates are governed and defensible.
Complere links validation documentation to change control, CAPA, and audit trails so your platform stays validated even as the configuration evolves.
Inspectors examine risk-based planning, traceability from requirements to testing, change control, and evidence that periodic review keeps the system in a validated state.
FDA 21 CFR Part 11, EU GMP Annex 11 & 15, MHRA, and WHO expect risk-based lifecycle validation for computerized systems.
Validation establishes a documented foundation for intended use and testing, while verification checks specific outputs comply with those validated controls.
Validation demonstrates with documented evidence that systems, processes, and equipment consistently perform as intended and remain compliant over time.
Complere helps regulated teams work from a more controlled platform environment, supported by structured validation documentation and clearer lifecycle evidence around change and periodic review.
Validation-ready documentation | Controlled lifecycle evidence | Stronger audit support
